Patents. NIH declines to march in on pricing AIDS drug.
David
D
Malakoff
D000163:Acquired Immunodeficiency Syndrome; D019380:Anti-HIV Agents / Q000191:economics*; D016527:Drug Costs; D004345:Drug Industry; D006801:Humans; D009316:National Institutes of Health (U.S.) / Q000331:legislation & jurisprudence*; D010330:Patents as Topic; D010344:Patient Advocacy; D019438:Ritonavir / Q000191:economics*; D014481:United States
D019380:Anti-HIV Agents; D019438:Ritonavir